Likewise, temozolomide could elicit the cyclooxygenase-2 expression in glioma cells, resulting in the upregulation of cyclooxygenase-2-carrying EVs, which have the activity to shift the M2-like pro-tumor phenotype of macrophage (103). This evidence concerns the gene PTGS2 and central nervous system cancer.